Kutki (Picrorhiza kurroa)

Kutki (Picrorhiza kurroa) is a bitter rhizomatous herb valued primarily for its bioactive phytochemical content rather than macronutrient contribution. Key bioactive compounds include: Iridoid glycosides — collectively termed 'kutkins' (3–5% of dry rhizome weight), comprising picroside I (~1.5–2.5%) and picroside II (kutkoside) (~0.8–1.5%), which are the principal hepatoprotective and immunomodulatory agents. Cucurbitacin glycosides are present in trace amounts contributing to anti-inflammatory activity. Phenolic compounds include vanillic acid, apocynin (acetovanillone, ~0.1–0.3%), and ferulic acid, which provide antioxidant and anti-inflammatory effects. Phenylethanoid glycosides such as picein and androsin are present at ~0.2–0.5%. The rhizome also contains minor amounts of beta-sitosterol, betulinic acid, and traces of catechol and d-mannitol (~0.5–1%). Mineral content is modest, with trace levels of iron, zinc, manganese, and magnesium typical of high-altitude Himalayan rhizomes. Fiber content in raw rhizome is moderate (~10–15% crude fiber by dry weight), while protein content is low (~3–6%). Fat content is negligible (<1%). The herb contains small quantities of vitamins (trace vitamin C and B-complex). Bioavailability notes: Picroside I and II are water-soluble iridoid glycosides with moderate oral bioavailability; absorption is enhanced when taken with warm water or mild fat-containing vehicles. Apocynin demonstrates good oral absorption but undergoes significant first-pass hepatic metabolism. Standardized commercial extracts are typically concentrated to 4–10% kutkins (picrosides I and II combined) to ensure therapeutic efficacy. The bitter taste profile itself stimulates gastric and hepatic secretions, contributing to the herb's digestive benefits via cephalic-phase reflex activation.